GeminIQ Website Logo

Viewing VCNX free

Subscribe for full history, 90+ metrics, screener, watchlist...

VACCINEX, INC.

VCNX

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
13032023671117
Accounts Receivable Net Current
1113110-00--
Assets Current
Assets Current
35273234781218
Prepaid Expense And Other Assets Current
111111111111
Derivative Assets Current
00000-------
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
000000000000
Assets
35274335891318
Liabilities And Stockhold…
Accounts Payable Current
453224212001
Accrued Liabilities Current
112212211111
Liabilities Current
Liabilities Current
565566323212
Contract With Customer Liability Current
00000-------
Long Term Debt Current
000000000000
Operating Lease Liability
----------00
Operating Lease Liability Current
0000000000--
Derivative Liabilities Current
00002000----
Long Term Debt Noncurrent
0--000000000
Operating Lease Liability Noncurrent
-----00000--
Liabilities
565566423222
Stockholders Equity Inclu…
Preferred Stock Value
22110-------
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
354352345345338333331327325321321321
Treasury Stock Value
-0-0-0-0-0-0-0-0-0-0-0-0
Retained Earnings Accumulated Deficit
-359-355-349-344-340-337-332-325-320-315-310-304
Stockholders Equity
-2-1-33-2-4-02561116
Liabilities And Stockholders Equity
35274335891318
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.001-------
Preferred Stock Shares Authorized
101010100-------
Preferred Stock Shares Issued
00000-------
Preferred Stock Shares Outstanding
00000-------
Preferred Stock Liquidation Preference Value
1,7501,7501,7501,7500-------
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
100100100100100100100100100100100100
Common Stock Shares Issued
332215440333
Shares Outstanding
33-215440333
Treasury Stock Common Shares
000000000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202431.97%17.94%-7.10%8.27%-50.96%-43.27%7.12%-67.12%-67.12%-21.84%-1.15%-19.54%
202315.00%-10.00%-32.50%-12.50%-69.44%-74.17%-22.22%-20.00%-33.33%-12.86%-19.28%-8.82%
20227.63%0.00%-12.71%-31.78%-44.86%-46.73%10.17%8.47%0.00%0.00%0.00%-5.00%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.50
0.77
0.42
1.52
0.57
0.35
0.79
1.91
2.95
4.04
8.22
10.00
Quick Ratio
0.38
0.63
0.25
1.24
0.42
0.17
0.57
1.44
2.59
3.64
7.65
9.46
Working Capital
-2.55M
-1.42M
-3.03M
2.45M
-2.57M
-4.16M
-704.00K
2.11M
4.94M
6.04M
10.77M
15.99M
Leverage & Debt
Debt to Equity
-2.04
-4.67
-1.83
1.77
-2.57
-1.66
-8.29
1.04
0.54
0.36
0.15
0.12
Interest Coverage TTM
-
-
-
-22,973.00
-22,885.00
-11,508.00
-7,324.67
-6,766.00
-4,976.50
-1,068.68
-128.60
-40.87
Debt Ratio
1.96
1.27
2.21
0.64
1.64
2.51
1.14
0.51
0.35
0.27
0.13
0.11
Efficiency & Turnover
Asset Turnover TTM
0.19
0.10
0.13
0.02
0.10
0.14
0.11
0.07
0.03
0.00
0.00
0.00
Days Sales Outstanding TTM
546.29
902.15
541.35
8,168.35
363.72
225.66
4.87
-
232.27
365.00
-
-
Receivables Turnover TTM
0.67
0.40
0.67
0.04
1.00
1.62
75.00
-
1.57
1.00
-
-
Per Share Metrics
Diluted EPS TTM
-8.88
-9.17
-9.77
-14.46
-43.68
-68.33
-75.97
-84.97
-98.05
-6.81
-6.96
-7.89
Free Cash Flow Per Share TTM
-7.72
-7.83
-8.67
-12.69
-37.31
-56.84
-67.40
-81.13
-94.90
-6.93
-7.59
-8.98
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-3,117.30%
-5,241.24%
-6,072.47%
-18,526.61%
-4,014.91%
-2,895.09%
-2,663.52%
-2,460.36%
-7,238.55%
-40,610.00%
-41,152.00%
-41,688.00%
Net Profit Margin TTM
-3,100.50%
-4,787.89%
-4,987.92%
-15,472.58%
-3,552.81%
-2,768.81%
-2,649.58%
-2,446.30%
-7,205.45%
-38,736.00%
-39,630.00%
-40,802.00%
Growth Metrics
Net Revenue Growth (1Y)
5.44%
-51.19%
-56.85%
-84.97%
107.27%
1,490.00%
1,550.00%
1,550.00%
-69.44%
-94.44%
-96.61%
-96.61%
Net Income Growth (1Y)
-7.98%
-15.61%
-18.77%
-4.94%
2.20%
13.65%
10.32%
-1.07%
-11.46%
-19.95%
-28.58%
-27.85%
EPS Growth (1Y)
-79.67%
-86.59%
-87.14%
-82.99%
-55.46%
903.42%
991.08%
976.69%
743.07%
-42.18%
-52.16%
-47.05%
Valuation Metrics
P/E TTM
-0.11
-0.37
-0.66
-0.51
-0.21
-0.23
-1.00
-0.99
-1.37
-15.42
-32.57
-35.13
P/B TTM
-0.83
-5.22
-4.12
3.70
-1.85
-1.32
-51.42
8.31
5.23
47.27
58.98
44.27
P/S TTM
3.42
17.76
33.13
79.31
7.52
6.41
26.37
24.18
98.76
5,972.97
12,908.06
14,332.22
Market Cap
2.06M
6.89M
11.80M
9.83M
4.28M
5.10M
21.75M
19.95M
27.16M
298.65M
645.40M
716.61M
Enterprise Value
974.97K
4.03M
11.63M
6.94M
2.85M
5.09M
19.98M
16.79M
20.94M
291.66M
634.22M
700.04M
Calculated Values
Free Cash Flow TTM
-16.21M
-15.87M
-15.77M
-16.84M
-17.30M
-18.31M
-19.39M
-19.27M
-19.18M
-19.72M
-21.59M
-23.21M
Net Debt
-1.08M
-2.86M
-170.00K
-2.89M
-1.43M
-8.00K
-1.77M
-3.17M
-6.22M
-6.99M
-11.19M
-16.57M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-08-09Purchase
Owner: Friedberg, Albert, Fcmi P…
Title: -
Shares: 100
Price/Share: $4.51
Value: $451.00
Shares Owned: 780,624
Relationship: TenPercentOwner
Ownership: Indirect
2024-08-06Purchase
Owner: Fcmi, Parent Co., Friedbe…
Title: -
Shares: 2,753
Price/Share: $4.92
Value: $13,544.76
Shares Owned: 780,524
Relationship: Director,TenPercentOwner
Ownership: Indirect
2024-08-01Purchase
Owner: Friedberg, Albert, Fcmi P…
Title: -
Shares: 11,703
Price/Share: $4.72
Value: $55,238.16
Shares Owned: 774,118
Relationship: TenPercentOwner
Ownership: Indirect
2024-07-31Purchase
Owner: Fcmi, Parent Co., Friedbe…
Title: -
Shares: 200,000
Price/Share: $6.52
Value: $1,304,000.00
Shares Owned: 762,415
Relationship: Director,TenPercentOwner
Ownership: Indirect
2024-05-30Purchase
Owner: Friedberg, Albert, Fcmi P…
Title: -
Shares: 861
Price/Share: $5.20
Value: $4,477.20
Shares Owned: 562,415
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2024-12-31
0.00%
Inst. Shares: 53
Shares Outstanding: 2,098,947
2024-09-30
16.55%
Inst. Shares: 335,433
Shares Outstanding: 2,026,920
2024-06-30
17.72%
Inst. Shares: 322,071
Shares Outstanding: 1,817,520
2024-03-31
24.30%
Inst. Shares: 322,526
Shares Outstanding: 1,327,257
2023-12-31
-
Inst. Shares: 1,571,650
Shares Outstanding: 463,653

VACCINEX, INC. (VCNX) — SEC Financial Statements & Analysis

VACCINEX, INC. (VCNX) is a pharmaceutical preparations company, incorporated in DE. VACCINEX, INC. trades on OTC as: VCNX. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), VACCINEX, INC. reported a 5.44% year-over-year revenue growth, a Debt-to-Equity ratio of -2.04x, a Price-to-Sales (P/S) ratio of 3.42x (TTM), a Price-to-Book (P/B) ratio of -0.83x (TTM), at a market cap of $2.06M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
5.44%
Debt To Equity
-2.04x
P/S TTM
3.42x
P/B TTM
-0.83x
Market Cap
$2.06M

Data as of 2024-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is VACCINEX, INC. in?

VACCINEX, INC. (VCNX) operates in the Pharmaceutical Preparations industry.

What is VCNX's market cap?

VACCINEX, INC. (VCNX) has a market capitalization of $2.06M as of 2024-12-31.

What exchange does VCNX trade on?

VACCINEX, INC. (VCNX) trades on the OTC.

Where is VACCINEX, INC. incorporated?

VACCINEX, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.